Stock Analysis: DOD Biotech

DOD Biotech Public Company Limited manufactures nutraceuticals and dietary supplements in Samut Sakhon.

Company: DOD Biotech Public Company Limited

Bloomberg ticker: DOD TB

Market cap: US$23m

Background: DOD Biotech Public Company Limited manufactures nutraceuticals and dietary supplements in Samut Sakhon. Its core services include full OEM/ODM manufacturing for supplements (soft gels, capsules, tablets), herbal extract production, beauty products, and R&D services for health brands.

World Class Benchmarking of DOD Biotech



 

  • Profitable Growth rank of 5 was up compared to the prior period’s 9th rank

  • This is average performance compared to 300 small Cons Staples companies worldwide

  • Profitability rank of 5 was worse than its Growth rank of 3

  • Profitability rank of 5 was up compared to the prior period’s 8th rank

  • This is average performance compared to peers

  • Growth rank of 3 was up compared to the prior period’s 9th rank

  • This is above average performance compared to peers

Comments